A publication involving carbetocin was released on October 13, 2026. The article, titled "Oxytocin versus Carbetocin: Preventing Postpartum Hemorrhage in Elective C-section," appeared in Annals of African Medicine. Carbetocin remains classified as unapproved for research use. The publication is listed under this title and journal as a new entry in the literature. No findings, outcomes, or comparative results from the publication are described here. This brief reports only that the publication exists, its title, its journal, and its date of listing. Readers interested in the subject matter of oxytocin and carbetocin in the context of postpartum hemorrhage prevention during elective cesarean section may wish to consult the original source directly for any reported details. No efficacy, safety, or statistical information is included in this notice, as none was provided beyond the publication's title and journal placement. This brief does not characterize or summarize the content, methodology, or conclusions of the study. For additional background on carbetocin generally, readers can refer to the compound overview for more context.
New Publication Compares Carbetocin and Oxytocin in Elective C-section
See the full carbetocin overview
Source: https://pubmed.ncbi.nlm.nih.gov/42860922/